Viatris Inc. (VTRS) Stock Price & Analysis
Market: NASDAQ • Sector: Healthcare • Industry: Drug Manufacturers - Specialty & Generic
Viatris Inc. (VTRS) Profile & Business Summary
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
Key Information
| Ticker | VTRS |
|---|---|
| Leadership | Scott Andrew Smith |
| Exchange | NASDAQ |
| Official Site | https://www.viatris.com |
Market Trend Overview for VTRS
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
This model looks at how prices behave over time to describe the current market environment. It focuses on whether price is moving steadily, stalling, or losing momentum, and checks both short-term and weekly trends for confirmation. The goal is not to predict exact prices, but to help understand when conditions are supportive, risky, or unclear.
Current Market Context (Short-Term)
As of 2026-02-06 (ET), VTRS is moving higher, but looks stretched. Price at 14.58 is above support near 14.04. If price moves higher, it may meet resistance around 15.12. View Support & Resistance from Options
Why the market looks this way?
The broader trend is still moving higher across timeframes. However, prices have risen quickly or recent advances show weaker participation. This increases the risk of short-term pullbacks if momentum fades.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-02-06 (ET)
As of 2026-02-06, VTRS is in a strong upward move. Over the longer term, the trend remains bullish.
VTRS last closed at 14.58. The price is about 3.0 ATR above its recent average price (13.84), and the market is currently in a strong upward move.
The broader uptrend is still intact, but price has moved far from its recent average, increasing the risk of a pullback.
Trend score: 95 out of 100. Overall alignment is strong. The market is currently in a strong and established uptrend. Trend signals are well aligned across timeframes, suggesting a stable and consistent trend.
Price is far from its recent average (about 3.0 ATR away). Chasing the move at this level carries a higher risk of a pullback.
A key downside level is near 12.09. If price falls below this area, the current upward trend would likely weaken or break.
A systematic trend-activation signal was most recently triggered on 2025-11-05, reflecting a technical shift toward positive directional alignment.
[2026-02-02] Moderate participation supported a steady price advance.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
Closing activity showed limited conviction and did not suggest strong overnight positioning.
Short Interest & Covering Risk for VTRS
This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.
Shows how likely a short squeeze may be under current market conditions.
Short Exposure Percentile
Short interest is well above normal levels, increasing the risk of forced covering and sudden price moves. (Historical percentile: 82%)
Structure Analysis
VTRS Short positioning looks normal. Current days to cover is 2.6 trading days, meaning short positions could unwind at a normal pace. Short covering is likely to have a normal impact on price moves.
Bull Trap Structural Risk
No clear bull trap characteristics detected. Recent price behavior remains broadly consistent with current positioning.This reading helps confirm that current price action remains structurally healthy and does not indicate elevated trap risk.
In the latest reporting period, short interest continues to increase. As a result, similar news or market events could lead to price moves about 1× larger than usual.
Note:
Short interest data is reported every two weeks by
FINRA.
The most recent snapshot is
2026-01-15 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.